


Foodtech Pioneer Impossible Foods Sues Competitor Motif for Patent Infringement

Enablement Ruling Extinguishes Broad Antibody Claims, What Comes Next?

mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook

FDA Approves Coherus’ Adalimumab Biosimilar YUSIMRY™
Subscribe: Subscribe via RSS
Firm/Org